Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vilin Bio MedNSE:VILINBIO +4.93%69 Days Inventory is 37.02 as of Mar. 2026, which is 54% below its 10-year median of 80.49. GuruFocus rates NSE:VILINBIO with a GF Score™ of 69/100 and a GF Value™ of ₹75.10 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 918 Drug Manufacturers companies, Vilin Bio Med ranks better than 88.02% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Vilin Bio Med's Average Total Inventories for the
six
months ended in Mar. 2026 was ₹58.1 Mil. Vilin Bio Med's Cost of Goods Sold for the
six
months ended in Mar. 2026 was ₹286.6 Mil.
Hence, Vilin Bio Med's Days Inventory for the
six
months ended in Mar. 2026 was 37.02.
The historical rank and industry rank for Vilin Bio Med's Days Inventory or its related term are showing as below:
NSE:VILINBIO'
s Days Inventory Range Over the Past 10 Years
Min: 54.98 Med: 80.49 Max: 120.28
Current: 74.04
During the past 7 years, Vilin Bio Med's highest Days Inventory was 120.28. The lowest was 54.98. And the median was 80.49.
NSE:VILINBIO's Days Inventory is ranked better than 88.02% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.53
vs NSE:VILINBIO: 74.04
Vilin Bio Med's Days Inventory
declined
from Sep. 2024 (207.13) to Mar. 2026 (37.02).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vilin Bio Med's Inventory Turnover for the
six
months ended in Mar. 2026 was 4.93.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vilin Bio Med's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.18.
Vilin Bio Med (NSE:VILINBIO) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vilin Bio Med's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vilin Bio Med's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vilin Bio Med Days Inventory Related Terms
Vilin Bio Med Days Inventory Historical Data
* Premium members only.
The historical data trend for Vilin Bio Med's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vilin Bio Med's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vilin Bio Med Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vilin Bio Med's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vilin Bio Med's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vilin Bio Med (NSE:VILINBIO) has a Days Inventory of 37.02 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vilin Bio Med and its competitors. This is 54% below median its historical median of 80.49. Over the past decade, Vilin Bio Med's Days Inventory has ranged from 54.98 to 120.28. According to the industry distribution chart, Vilin Bio Med ranks #110 out of 918 companies in the Drug Manufacturers industry, placing it in the top 12%.
Is Vilin Bio Med's Days Inventory too high?
Vilin Bio Med's current Days Inventory of 37.02 is 54% below median its 10-year median of 80.49. Over the past 10 years, this metric has ranged from a low of 54.98 to a high of 120.28. The Drug Manufacturers industry median Days Inventory is 164.53. Vilin Bio Med's value of 37.02 is 77.5% below this industry median. Based on the distribution chart, Vilin Bio Med ranks #110 out of 918 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vilin Bio Med has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vilin Bio Med's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vilin Bio Med ranks #110 out of 918 companies for Days Inventory. This places Vilin Bio Med in the top 12% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.53. Vilin Bio Med's value of 37.02 is 77.5% below this benchmark. Historically, Vilin Bio Med's own Days Inventory has ranged from 54.98 to 120.28 over the past decade. While the company's 10-year median is 80.49 vs. the industry median of 164.53, Vilin Bio Med has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.53, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vilin Bio Med's current Days Inventory of 37.02 is 77.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vilin Bio Med and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vilin Bio Med's current Days Inventory is 37.02, which is 54% below median its own 10-year median of 80.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vilin Bio Med stock overvalued right now?
Based on GuruFocus' analysis, Vilin Bio Med (NSE:VILINBIO) is currently considered Possible Value Trap. The stock's GF Value™ is ₹75.10, compared to a current price of ₹44.70 — trading 40.5% below its estimated fair value. The current Days Inventory is 37.02, which is 54% below median its 10-year median of 80.49 and 77.5% below the Drug Manufacturers industry median of 164.53. Vilin Bio Med's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vilin Bio Med (NSE:VILINBIO), the current Days Inventory is 37.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vilin Bio Med (NSE:VILINBIO) Overvalued in 2026?
Based on GuruFocus' analysis, Vilin Bio Med stock appears to be undervalued.
The current stock price of ₹44.70 is trading 40.5% below its estimated GF Value™ of ₹75.10.
GuruFocus considers Vilin Bio Med to be Possible Value Trap.
Key valuation signals for NSE:VILINBIO:
Days Inventory: 37.02 (54% below median its 10-year median of 80.49)
GF Value™: ₹75.10 vs. price of ₹44.70 (40.5% below fair value)
Industry Position: 77.5% below the Drug Manufacturers median (#110 of 918)
No single metric tells the full story. See the NSE:VILINBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules and Nutritional Food supplements.
69GF Score
Get the complete analysis for NSE:VILINBIO
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VILINBIO has been successfully added to your 
